EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive functional characterization of rare and known CYP2E1 allelic variants identified in a Japanese population

Yuki Ohmori, Eiji Hishinuma, Yuma Suzuki, Akiko Ueda, Caroline Mwendwa Kijogi, Tomoki Nakayoshi, Akifumi Oda, Sakae Saito, Shu Tadaka, Kengo Kinoshita, Yu Sato, Masahiro Hiratsuka

Biochemical Pharmacology · 2025

DOI: 10.1016/j.bcp.2025.117396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2025. Verfasst von Yuki Ohmori und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan. Hauptthemen laut MEDLINE: Alleles, Cytochrome P-450 CYP2E1, Genetic Variation, East Asian People. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Naito Foundation, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytochrome P450 2E1 (CYP2E1) is a key hepatic enzyme involved in the oxidative metabolism of low-molecular-weight xenobiotics, including drugs, anesthetics, and procarcinogens. Although numerous CYP2E1 genetic variants have been identified, their functional implications remain unclear. In this study, we systematically characterized 25 CYP2E1 variants-22 novel missense variants identified via whole-genome sequencing of 8,380 Japanese individuals, and three PharmVar-defined alleles (*2, *3, and *4). The wild-type and variant enzymes were expressed in 293FT cells, and protein levels were quantified by Western blotting. Enzyme activity was evaluated by measuring chlorzoxazone 6-hydroxylation, and kinetic parameters (Km, Vmax, CLint) were derived from Michaelis-Menten analysis. Five variants exhibited significantly reduced catalytic activity, while two showed increased function. One frameshift variant, Leu447fs, resulted in complete loss of activity. In silico 3D docking simulations using a homology-modeled CYP2E1 structure revealed that several function-altering variants were located near the heme-binding domain or substrate recognition sites. Structural analysis of the Leu133His variant suggested that disruption of hydrogen bonding networks near the heme could underlie its reduced activity. The three known star alleles showed no significant deviation from wild-type activity. These findings provide important mechanistic insights into the functional consequences of rare CYP2E1 variants and underscore the enzyme's structural resilience. Our results offer foundational data for interpreting CYP2E1 genetic variation and support future efforts in personalized medicine through pharmacogenomic profiling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllelesCytochrome P-450 CYP2E1Genetic VariationEast Asian PeopleHumansMaleHEK293 CellsJapanMolecular Docking Simulation

Stichwörter der Autor:innen

2-Benzoxazolinone (PubChem CID: 6043)5-Aminolevulinic acid hydrochloride (PubChem CID: 123608)6-hydroxy chlorzoxazone (PubChem CID: 2734)CYP2E1Chlorzoxazone (PubChem CID: 2733)Cytochrome P450Disodium Dihydrogen Ethylenediaminetetraacetate Dihydrate (PubChem CID: 636371Drug metabolismGenetic polymorphismsIron(Ⅱ) sulfate heptahydrate (PubChem CID: 24393)Pharmacogenomicsdimanganese decacarbonyl (PubChem CID: 517769)

Substanzen

Cytochrome P-450 CYP2E1

Autor:innen und Institutionen

  • Laboratory of Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
  • Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University, Sendai 980-8573, Japan; Tohoku Medical Megabank Organization, Tohoku University, Sendai 980-8573, Japan.
  • Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University, Sendai 980-8573, Japan.
  • Laboratory of Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan; Department of Pharmacy, Faculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan.
  • Department of Pharmacy, Faculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan.
  • Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University, Sendai 980-8573, Japan; Tohoku Medical Megabank Organization, Tohoku University, Sendai 980-8573, Japan; Graduate School of Inform…

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Naito Foundation
  • Japan Agency for Medical Research and Development

Zitieren

APA

Ohmori, Y., Hishinuma, E., Suzuki, Y., Ueda, A., Kijogi, C. M., Nakayoshi, T., Oda, A., Saito, S., Tadaka, S., Kinoshita, K., Sato, Y., & Hiratsuka, M. (2025). Comprehensive functional characterization of rare and known CYP2E1 allelic variants identified in a Japanese population. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117396

Vancouver

Ohmori Y, Hishinuma E, Suzuki Y, Ueda A, Kijogi CM, Nakayoshi T, et al. Comprehensive functional characterization of rare and known CYP2E1 allelic variants identified in a Japanese population. Biochemical Pharmacology. 2025. doi:10.1016/j.bcp.2025.117396

BibTeX
@article{Ohmori2025,
  author = {Ohmori, Yuki and Hishinuma, Eiji and Suzuki, Yuma and Ueda, Akiko and Kijogi, Caroline Mwendwa and Nakayoshi, Tomoki and Oda, Akifumi and Saito, Sakae and Tadaka, Shu and Kinoshita, Kengo and Sato, Yu and Hiratsuka, Masahiro},
  title = {Comprehensive functional characterization of rare and known CYP2E1 allelic variants identified in a Japanese population},
  journal = {Biochemical Pharmacology},
  year = {2025},
  doi = {10.1016/j.bcp.2025.117396}
}
Kostenlos starten →